|
|
 |
Maternal Antidepressant use can cause Infant Structural Brain Damage
by Ralph Teller |
|
SSRI use causes children to experience headaches and problems with balance to require surgery
Maternal antidepressant use may be associated with structural brain changes in infants, according to a recent study lead by Rebecca Knickmeyer, PhD. an assistant professor at the University of North Carolina at Chapel Hill.
The study showed that the offspring of mothers who used selective serotonin reuptake inhibitors (SSRI - antidepressants) during pregnancy were significantly more likely to develop Chiari type I brain malformation (CIM).
Some of these defects caused the children to experience headaches and problems with balance severe enough to require surgery.
The most commonly used antidepressant by the mothers in the study was sertraline (Zoloft, Pfizer Inc), followed by fluoxetine and citalopram.
Overall, the study found a striking increase in the brain abnormality CIM in children with prenatal SSRI exposure.
Recently, a doctor group has sought to limit antipsychotics use, including antidepressants, due to harmful side effects in infants, children, adolescents and adults. Hopefully this group will help convince their fellow doctors against the widespread prescription of these dangerous medications. See Doctor Group seeks to Limit Antipsychotics use due to Harmful Side Effects
More about Ralph Teller. See Ralph's 1Vigor Log Calendar.
<-- back to top |
1Vigor Log Contest
Win Prizes! Prizes to the Male and Female who logs the most distance running, hiking, swimming, cycling, pushups on the 1Vigor Log . . . Read more |
Books on 1Vigor
Recommended reading on swimming, running, cycling, adventure, natural health, nutrition, brain power, nerve force, men's health, hiking, women's health . . . See Books! |
Antipsychotics Articles
 Maternal Antidepressant Use Linked to Infant Brain Malformations, Deborah Brauser, Medscape
Rate of Chiari I Malformation in Children of Mothers with Depression with and without Prenatal SSRI Exposure, Rebecca C Knickmeyer, Neuropsychopharmacology
Five Things Physicians and Patients Should Question, Choosing Wisely, American Psychiatric Association Antipsychotics Increase Risk of Type 2 Diabetes in Children and Young Adults, Alba Morales Pozzo, MD; Chief Editor: Stephen Kemp, MD, PhD, Medscape
Implications of Marked Weight Gain Associated With Antipsychotic
Medications in Children and Adolescents
, Christopher K. Varley, MD and Jon McClellan, MD, JAMA
Children and adolesents experience substantial antipsychotic medication caused weight gain and adverse metabolic effects, with more than half gaining more than 7% of their
total body weight.
Smoking and Mental Illness: Results From Population Surveys in Australia and the United States
, David Lawrence; Francis Mitrou; Stephen R Zubrick, BMC Public Health
Antidepressants Linked to Increased Risk for Death, Stroke in Postmenopausal Women
, Pam Harrison, Department of Community Health Sciences, University of Calgary, Medscape
Weight Gain in Relation to Major Depression and Antidepressant Medication Use
, Patten SB, Medscape Medical News
Antidepressants May Only Be Effective in Treatment of the Severest Depression
, Caroline Cassels, Medscape Medical News
Whole Diet May Ward Off Depression and Anxiety
, Caroline Cassels, Medscape Medical News
Unintentional Drug Poisoning (overdose) Deaths: A National Epidemic
, Bret Stetka, MD, Medscape
Broad Review of FDA Trials Suggests Antidepressants Only Marginally Better than Placebo, Deborah Brauser, Medscape
Antidepressant Use Linked with Increased Artherosclerosis Measured by Carotoid IMT, Heartwire, Medscape
Mom's Antidepressant Use Linked to Autism Risk in Children, Psychiatry, Medscape
More Evidence Confirms Diet's Link to Mental Health, Caroline Cassels, Psychiatry, Medscape
Tricyclic Antidepressants Linked to Increased Cardiovascular Risk, Megan Brooks, Medscape
|
